Aminoglycoside Antibacterial [EPC]

26447 reported adverse events

Drugs of this class: TOBRAMYCIN TOBRAMYCIN AND DEXAMETHASONE TOBRAMYCIN INHALATION SOLUTION AMIKACIN GENTAMICIN, PREDNISOLONE ACETATE LOTEPREDNOL ETABONATE AND TOBRAMYCIN TOBRAMYCIN / DEXAMETHASONE TOBRAMYCIN INHALATION TOBRAMYCIN OPHTHALMIC SOLUTION

These side effects are most commonly reported by patients taking drugs of the Aminoglycoside Antibacterial [EPC] class:

# Side effect Count
0 DEATH 1676
1 OFF LABEL USE 1645
2 DYSPNOEA 1604
3 COUGH 1563
4 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1415
5 PNEUMONIA 1257
6 DRUG INEFFECTIVE 1108
7 CYSTIC FIBROSIS 968
8 CONDITION AGGRAVATED 947
9 PYREXIA 946
See all common reactions for Aminoglycoside Antibacterial [EPC]

Drugs of the Aminoglycoside Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1415 0.3220
1 CYSTIC FIBROSIS LUNG 27 0.2967
2 CYSTIC FIBROSIS RELATED DIABETES 18 0.2727
3 CYSTIC FIBROSIS 968 0.2493
4 MYCOBACTERIUM ABSCESSUS INFECTION 71 0.2113
5 GEOTRICHUM INFECTION 29 0.2071
6 INFECTIVE EXACERBATION OF BRONCHIECTASIS 34 0.1910
7 CHOROIDITIS 36 0.1659
8 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 114 0.1638
9 DISTAL INTESTINAL OBSTRUCTION SYNDROME 26 0.1421
See all enriched reactions for Aminoglycoside Antibacterial [EPC]